Trending in India · Sports · Last observed Jul 21, 2026
takeda dengue vaccine trending in India
India has approved the first dengue vaccine, Takeda’s QDENGA, spurring a 700% increase in searches as people seek information about this new health development.
The subject, explained
What is driving the attention?
The recent approval of Takeda’s QDENGA as India’s first dengue vaccine has generated significant public interest, visible in a 700% rise in related searches. Numerous reputable news sources discuss the vaccine's authorization by the Drug Controller General of India (DCGI), highlighting its protection against dengue for individuals aged 4 to 60 years. People are searching to understand the vaccine's effectiveness, availability, and implications for dengue prevention in India.
Search trail
Questions orbiting this topic
Related queries observed alongside the main signal.
Reporting and context
Sources connected to this search
The Hindu
India approves first dengue vaccine for individuals aged 4 to 60 years - The HinduIndia approves first dengue vaccine for individuals aged 4 to 60 years The Hindu Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India Reuters India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained NDTV Takeda dengue vaccine Qdenga wins marketing approval in India ETPharma.com India Gets Its First Dengue Vaccine as DCGI Approves Takeda's QDENGA Medical Dialogues India’s first dengue vaccine approved: DCGI clears Takeda’s Qdenga for those aged 4 to 60 The Indian Express India gets first dengue vaccine as DCGI approves Takeda’s QDENGA | Hindustan Times Hindustan Times How effective is QDENGA? India approves its first dengue vaccine by Japanese drugmaker for ages 4-60 theweek.in Takeda gets DCGI approval for QDENGA, India's first dengue vaccine Business Standard
Continue exploring